AntibioticsINTRAMUSCULAR, INTRAVENOUSStandard
PENICILLIN G SODIUM
PENICILLIN G SODIUM
Standard Dose
5,000,000 UNITS/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PENICILLIN G SODIUM is listed in Drugs@FDA under application 065068 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PENICILLIN G SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - 5,000,000 UNITS/VIAL Sponsor SANDOZ Submission history Latest submission status date: 2020-06-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview PENICILLIN G SODIUM is listed in Drugs@FDA under application 065068 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PENICILLIN G SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - 5,000,000 UNITS/VIAL Sponsor SANDOZ Submission history Latest submission status date: 2020-06-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.